NUCLIDIUM Secures $105 Million in Latest Series B Funding Round

NUCLIDIUM secured $105 million in its latest Series B, adding another data point to the Enterprise Technology funding market.

NUCLIDIUM Raises $105 million in Funding

NUCLIDIUM is a Enterprise Technology company focused on CHF 105 Million.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

NUCLIDIUM operates in Enterprise Technology. NUCLIDIUM's Series B round shows investors are still backing enterprise technology platforms with sharper category positioning. At $105M, the deal suggests capital is still rewarding teams that can translate product focus into durable growth signals.

Strategic Use of Funds

CHF 105 Million

Looking Ahead

NUCLIDIUM Announces Closing of Series B Extension Bringing Total Round to CHF 105 Million

Source reference: original announcement/article.